Hepatitis B and C Within the Chinese Community in Milan
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-50
SponsorIRCCS Ospedale San Raffaele
About this trial
The goal of this observational study is to assess the effectiveness of targeted screening for Hepatitis B (HBV) and Hepatitis C (HCV) infections in adults aged 18 to 50 from the Chinese community residing in Milan.
The main questions it aims to answer are:
* Does community-based, culturally sensitive screening increase the detection of undiagnosed HBV and HCV infections in this high-risk population? * What is the level of adherence, satisfaction and awareness regarding rapid testing methods in this community?
Participants will:
* Receive pre-test counseling in Italian or Chinese with the help of an interpreter * Complete a brief, anonymous questionnaire on demographics, risk factors and awareness of HBV/HCV * Undergo capillary rapid testing for HBV and/or HCV * Receive test results during the same visit * Complete a short post-test satisfaction questionnaire
The study will be conducted in public spaces within Milan's Chinatown, during monthly sessions, until 1,000 participants are enrolled. Each session will last approximately 30-60 minutes per participant.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 to 50 years
Self-identified as part of the Chinese community residing in Milan
Willing and able to provide informed consent
Willing to undergo HBV and/or HCV rapid screening (capillary blood test)
Disqualifiers
Age under 18 or over 50 years
Not from the Chinese community or not residing in Milan
Unable to provide informed consent
Currently undergoing treatment for HBV or HCV, or with previously confirmed diagnosis of HBV or HCV
Trial population
Adults aged 18 to 50 years who self-identify as part of the Chinese community residing in Milan. Participants must be able to provide informed consent, complete a short questionnaire and undergo rapid testing for HBV and/or HCV. Both males and females are eligible. The study aims to reach individuals who may face cultural, linguistic or systemic barriers to healthcare access.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Detection rate of HBV and/or HCV infections
Proportion of participants from the Chinese community residing in Milan who test positive for Hepatitis B surface antigen (HBsAg) and/or anti-HCV antibodies using capillary rapid tests during the screening session
Time frame
Day 1 (during the screening session)Secondary outcomes
1
Adherence to rapid HBV/HCV testing
Proportion of participants who complete the full screening process, including pre-test counseling, informed consent, questionnaire and rapid testing
Time frame
Day 12
Acceptability of rapid testing methods
Participant satisfaction and perceived acceptability of the capillary rapid testing process, measured through a standardized post-test questionnaire
Time frame
Day 13
Demographic profile and risk factors of screened individuals
Distribution of age, sex and self-reported risk factors among participants who undergo screening
Time frame
Day 14
Awareness of HBV and HCV infections
Proportion of participants who report prior awareness or knowledge of HBV and/or HCV infections in the pre-test questionnaire
Time frame
Day 1Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: